142 related articles for article (PubMed ID: 32034211)
1. Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy.
Warner RB; Najy AJ; Jung YS; Fridman R; Kim S; Kim HC
Sci Rep; 2020 Feb; 10(1):2099. PubMed ID: 32034211
[TBL] [Abstract][Full Text] [Related]
2. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.
Duch P; Díaz-Valdivia N; Ikemori R; Gabasa M; Radisky ES; Arshakyan M; Gea-Sorlí S; Mateu-Bosch A; Bragado P; Carrasco JL; Mori H; Ramírez J; Teixidó C; Reguart N; Fillat C; Radisky DC; Alcaraz J
Matrix Biol; 2022 Aug; 111():207-225. PubMed ID: 35787446
[TBL] [Abstract][Full Text] [Related]
3. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of TIMP1, CD63, and β1-Integrin and the Functional Impact of Their Interaction in Cancer.
Justo BL; Jasiulionis MG
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502227
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma.
Najy AJ; Jung YS; Kim S; Fridman R; Kim HC
Cells; 2021 Oct; 10(10):. PubMed ID: 34685701
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW
BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123
[TBL] [Abstract][Full Text] [Related]
8. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
[TBL] [Abstract][Full Text] [Related]
9. TIMP-1 Promotes Oligodendrocyte Differentiation Through Receptor-Mediated Signaling.
Nicaise AM; Johnson KM; Willis CM; Guzzo RM; Crocker SJ
Mol Neurobiol; 2019 May; 56(5):3380-3392. PubMed ID: 30121936
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.
Jung KK; Liu XW; Chirco R; Fridman R; Kim HR
EMBO J; 2006 Sep; 25(17):3934-42. PubMed ID: 16917503
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE; Alonso DF; Yoshiji H; Thorgeirsson UP
Eur J Cell Biol; 1997 Oct; 74(2):111-22. PubMed ID: 9352216
[TBL] [Abstract][Full Text] [Related]
12. The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.
Rossi L; Forte D; Migliardi G; Salvestrini V; Buzzi M; Ricciardi MR; Licchetta R; Tafuri A; Bicciato S; Cavo M; Catani L; Lemoli RM; Curti A
Exp Hematol; 2015 Nov; 43(11):974-985.e1. PubMed ID: 26213230
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling.
Egea V; Zahler S; Rieth N; Neth P; Popp T; Kehe K; Jochum M; Ries C
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):E309-16. PubMed ID: 22223664
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.
Jung YS; Liu XW; Chirco R; Warner RB; Fridman R; Kim HR
PLoS One; 2012; 7(6):e38773. PubMed ID: 22701711
[TBL] [Abstract][Full Text] [Related]
15. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; Knaüper V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
17. Cytokine functions of TIMP-1.
Ries C
Cell Mol Life Sci; 2014 Feb; 71(4):659-72. PubMed ID: 23982756
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
Batra J; Robinson J; Soares AS; Fields AP; Radisky DC; Radisky ES
J Biol Chem; 2012 May; 287(19):15935-46. PubMed ID: 22427646
[TBL] [Abstract][Full Text] [Related]
19. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
Meng Q; Malinovskii V; Huang W; Hu Y; Chung L; Nagase H; Bode W; Maskos K; Brew K
J Biol Chem; 1999 Apr; 274(15):10184-9. PubMed ID: 10187802
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
Iyer S; Wei S; Brew K; Acharya KR
J Biol Chem; 2007 Jan; 282(1):364-71. PubMed ID: 17050530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
